SCHEMBL776945

SCHEMBL776945

CCCCCOS(=O)OCCCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.42
CA1 P00915 9/20 0.41
CA2 P00918 9/20 0.41
CA9 Q16790 8/20 0.41
LPAR3 Q9UBY5 3/20 0.39
CA12 O43570 3/20 0.39
CA7 P43166 3/20 0.39
CA14 Q9ULX7 3/20 0.39
LPAR1 Q92633 2/20 0.39
LPAR2 Q9HBW0 2/20 0.39
CA3 P07451 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CA5A P35218 2/20 0.39
CA5B Q9Y2D0 2/20 0.39
NAAA Q02083 1/20 0.39
RECQL P46063 2/20 0.38
TSHR P16473 2/20 0.38
CES2 O00748 1/20 0.38
GLA P06280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28431774 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL28083458 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL9129611 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL778726 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL4304767 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL28383874 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL28888136 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL4299797 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL9400299 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3
SCHEMBL246738 0.97 EPHX2 (0.46) EPHX2CA1CA2CA9LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119120089-A Method for realizing oil-based liquid super-slip in situ in super-slip system 清华大学 2024-12-13 CN claimed
US-11929257-B2 Etching solution and method for aluminum nitride VERSUM MATERIALS US, LLC (US) 2024-03-12 US claimed
CN-117510332-A New method for synthesizing 6, 8-dichloro octanoic acid ester 风火轮(上海)生物科技有限公司 2024-02-06 CN claimed
US-20220367199-A1 ETCHING SOLUTION AND METHOD FOR ALUMINUM NITRIDE VERSUM MATERIALS US, LLC (US) 2022-11-17 US claimed
EP-3959291-A1 ETCHING SOLUTION AND METHOD FOR ALUMINUM NITRIDE Versum Materials US, LLC (US) 2022-03-02 EP claimed
WO-2020185745-A1 ETCHING SOLUTION AND METHOD FOR ALUMINUM NITRIDE VERSUM MATERIALS US, LLC (US) 2020-09-17 WO claimed
US-20160354342-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE COMPOUND AND A GASTRIC ACID SECRETION INHIBITOR. SHAHID MUSLIM D (US) 2016-12-08 US claimed
CN-105917502-A Copolymers with polyacrylic acid backbone as performance enhancers for lithium ion batteries 路博润先进材料公司 2016-08-31 CN claimed
CN-102598389-B High voltage electrolyte TOYOTA ENG & MFG NORTH AMERICA 2015-04-01 CN claimed
CN-102598389-A High voltage electrolyte TOYOTA ENG & MFG NORTH AMERICA 2012-07-18 CN claimed
JP-55066563-A None JP disclosed
JP-55071607-A None JP disclosed
CN-122030497-A Fermentation method for cooperatively treating ganoderma lucidum by bacterial enzymes and application of fermentation method in pet food 杭州半边野兽科技有限公司 2026-05-15 CN disclosed
US-12428365-B2 Production method of acrylic acid derivative DAIKIN INDUSTRIES, LTD. (JP) 2025-09-30 US disclosed
CN-119581659-A Electrolyte and secondary battery 中南大学 2025-03-07 CN disclosed
US-20070231707-A1 Nonaqueous Electrolytic Solution and Lithium Secondary Battery MU IONIC SOLUTIONS CORPORATION (JP) 2007-10-04 US disclosed
EP-1772924-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY Ube Industries, Ltd. (JP) 2007-04-11 EP disclosed
JP-S5571607-A PRODUCTION OF DITHIONITE MITSUBISHI GAS CHEM CO INC 1980-05-29 JP disclosed
JP-S5566563-A PRODUCTION OF IMIDAZOLE DERIVATIVE SUMITOMO CHEM CO LTD 1980-05-20 JP disclosed
US-4177247-A Process for producing dithionites MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1979-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160354342-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE COMPOUND AND A GASTRIC ACID SECRETION INHIBITOR. ALAD, ALOX15B, FABP6 EPHX2 1130/4885CA1 172/4885CA2 573/4885
US-12428365-B2 Production method of acrylic acid derivative ADH1A, ALDH7A1, ALDH3A1 EPHX2 1926/4885CA1 147/4885CA2 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.